BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
100 hedge funds and large institutions have $150M invested in Bellicum Pharmaceuticals, Inc. in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 28 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+4
Holders Change %
+4.17%
% of All Funds
2.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
31
Reduced
28
Closed
8
Calls
$942K
Puts
$314K
Net Calls
+$628K
Net Calls Change
+$1.32M
Top Buyers
| 1 |
BlackRock
New York
|
+$1.96M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.89M |
| 3 |
JPMorgan Chase & Co
New York
|
+$1.85M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$842K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$616K |
Top Sellers
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$8.72M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.09M |
| 3 |
Millennium Management
New York
|
-$787K |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$664K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$645K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BG
101
Bellevue Group
Kuesnacht,
Switzerland
| – | -$664K | -9,002 | Closed |
|
102
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$621K | -8,418 | Closed |
|
|
BFM
103
Boothbay Fund Management
New York
| – | -$596K | -8,080 | Closed |
|
|
ECM
104
Endurant Capital Management
San Mateo,
California
| – | -$530K | -7,180 | Closed |
|
|
CS
105
Credit Suisse
Zurich,
Switzerland
| – | -$158K | -2,133 | Closed |
|
106
Simplex Trading
Chicago,
Illinois
| – | -$49K | -667 | Closed |
|
|
CF
107
Centaurus Financial
Anaheim,
California
| – | -$25K | -333 | Closed |
|
|
PIA
108
Piedmont Investment Advisors
Durham,
North Carolina
| – | -$5K | -69 | Closed |
|